journal article·2022-08-13Open access

Application of Injectable, Crosslinked, Fibrin-Containing Hyaluronic Acid Scaffolds for In Vivo Remodeling

Adél Hinsenkamp, Ágnes Fülöp, László Hricisák, Éva Pál, Kiara Kun, Aliz Majer, Viktória Varga, Zsombor Lacza, István Hornyák

Abstract

The present research aimed to characterize soft tissue implants that were prepared with the use of crosslinked hyaluronic acid (HA) using two different crosslinkers and multiple reagent concentrations, alone or in combination with fibrin. The effect of the implants was evaluated in an in vivo mouse model, after 4 weeks in one group and after 12 weeks in the other. The explants were compared using analytical methods, evaluating microscopic images, and a histology analysis. The kinetics of the degradation and remodeling of explants were found to be greatly dependent on the concentration and type of crosslinker; generally, divinyl sulfone (DVS) resists degradation more effectively compared to butanediol diglycidyl ether (BDDE). The presence of fibrin enhances the formation of blood vessels, and the infiltration of cells and extracellular matrix. In summary, if the aim is to create a soft tissue implant with easier degradation of the HA content, then the use of 2–5% BDDE is found to be optimal. For a longer degradation time, 5% DVS is the more suitable crosslinker. The use of fibrin was found to support the biological process of remodeling, while keeping the advances of HA in void filling, enabling the parallel degradation and remodeling processes.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Proteoglycans and glycosaminoglycans research · Electrospun Nanofibers in Biomedical Applications · Periodontal Regeneration and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Translational Medicine, Semmelweis University, H-1094 Budapest, Hungary

Orthosera Medical Zrt., H-1121 Budapest, Hungary

Institute of Sport and Health Sciences, University of Physical Education, H-1121 Budapest, Hungary

Funding

Hungarian National Research, Development and Innovation Office · The Central Library of Semmelweis University

References (43)

Show source-provided references
1. Synthetic polymer scaffolds for soft tissue engineering
2. Regenerative Medicine Build-Out10.5966/sctm.2015-0275 ↗
3. Engineering cell-derived matrices with controlled 3D architectures for pathophysiological studies10.1016/bs.mcb.2019.11.022 ↗
4. Controlled drug release for tissue engineering10.1016/j.jconrel.2015.08.049 ↗
5. Advancing biomaterials of human origin for tissue engineering10.1016/j.progpolymsci.2015.02.004 ↗
6. Soft-Nanoparticle Functionalization of Natural Hydrogels for Tissue Engineering Applications10.1002/adhm.201900506 ↗
7. Bayer, I.S. (2020). Hyaluronic Acid and Controlled Release: A Review. Molecules, 25.10.3390/molecules25112649 ↗
8. Valero, C., Amaveda, H., Mora, M., and García-Aznar, J.M. (2018). Combined experimental and computational characterization of crosslinked collagen-based hydrogels. PLoS ONE, 13.10.1371/journal.pone.0195820 ↗
9. Prolonged Culture of Aligned Skeletal Myotubes on Micromolded Gelatin Hydrogels10.1038/srep28855 ↗
10. Ribeiro, V.P., Silva-Correia, J., Gonçalves, C., Pina, S., Radhouani, H., Montonen, T., Hyttinen, J., Roy, A., Oliveira, A.L., and Reis, R.L. (2018). Rapidly responsive silk fibroin hydrogels as an artificial matrix for the programmed tumor cells death. PLoS ONE, 13.10.1371/journal.pone.0194441 ↗
11. Alven, S., and Aderibigbe, B.A. (2020). Chitosan and Cellulose-Based Hydrogels for Wound Management. Int. J. Mol. Sci., 21.10.3390/ijms21249656 ↗
12. Enzymatically degradable alginate hydrogel systems to deliver endothelial progenitor cells for potential revasculature applications10.1016/j.biomaterials.2018.06.038 ↗
13. Vasile, C., Pamfil, D., Stoleru, E., and Baican, M. (2020). New Developments in Medical Applications of Hybrid Hydrogels Containing Natural Polymers. Molecules, 25.10.3390/molecules25071539 ↗
14. Translational Applications of Hydrogels10.1021/acs.chemrev.0c01177 ↗
15. Fallacara, A., Baldini, E., Manfredini, S., and Vertuani, S. (2018). Hyaluronic Acid in the Third Millennium. Polymers, 10.10.3390/polym10070701 ↗
16. Hyaluronan fragments: An information-rich system10.1016/j.ejcb.2006.05.009 ↗
17. Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications10.1016/j.carbpol.2011.03.019 ↗
18. Physiochemical properties and application of hyaluronic acid: A systematic review10.1111/jocd.12237 ↗
19. Modification and cross-linking parameters in hyaluronic acid hydrogels—Definitions and analytical methods10.1016/j.carbpol.2012.08.066 ↗
20. Crosslinked Hyaluronic Acid Gels with Blood-Derived Protein Components for Soft Tissue Regeneration10.1089/ten.tea.2020.0197 ↗
21. The impact of hyaluronic acid oligomer content on physical, mechanical, and biologic properties of divinyl sulfone-crosslinked hyaluronic acid hydrogels10.1002/jbm.a.32704 ↗
22. Smooth muscle cell adhesion on crosslinked hyaluronan gels10.1002/jbm.10061 ↗
23. Hyaluronic acid and fibrin from L-PRP form semi-IPNs with tunable properties suitable for use in regenerative medicine10.1016/j.msec.2019.110547 ↗
24. Fibrinogen and fibrin10.1016/S0065-3233(05)70008-5 ↗
25. Fibrin Formation, Structure and Properties10.1007/978-3-319-49674-0_13 ↗
26. Use of platelet-rich fibrin in regenerative dentistry: A systematic review10.1007/s00784-017-2133-z ↗
27. Kardos, D., Hornyák, I., Simon, M., Hinsenkamp, A., Marschall, B., Várdai, R., Kállay-Menyhárd, A., Pinke, B., Mészáros, L., and Kuten, O. (2018). Biological and Mechanical Properties of Platelet-Rich Fibrin Membranes after Thermal Manipulation and Preparation in a Single-Syringe Closed System. Int. J. Mol. Sci., 19.10.3390/ijms19113433 ↗
28. Hinsenkamp, A., Kun, K., Gajnut, F., Majer, A., Lacza, Z., and Hornyák, I. (2021). Cell Attachment Capacity and Compounds of Fibrin Membranes Isolated from Fresh Frozen Plasma and Cryoprecipitate. Membranes, 11.10.3390/membranes11100783 ↗
29. Cryoprecipitate therapy10.1093/bja/aeu158 ↗
30. Cryoprecipitate: An outmoded treatment?10.1111/j.1365-3148.2012.01181.x ↗
31. Cryoprecipitate Utilization Patterns Observed With a Required Prospective Approval Process vs Electronic Dosing Guidance10.1093/ajcp/aqaa042 ↗
32. A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers10.1111/dsu.12301 ↗
33. Hyaluronic Acid Based Hydrogels for Regenerative Medicine Applications10.1155/2015/871218 ↗
34. Hyaluronic acid gel (Juvéderm) preparations in the treatment of facial wrinkles and folds10.2147/CIA.S3118 ↗
35. Hyaluronic acid gel fillers in the management of facial aging10.2147/CIA.S2135 ↗
36. Hinsenkamp, A., Kardos, D., Lacza, Z., and Hornyák, I. (2020). A Practical Guide to Class IIa Medical Device Development. Appl. Sci., 10.10.3390/app10103638 ↗
37. Overview of Tissue Engineering Patent Strategies and Patents from 2010 to 2020, Including Outcomes10.1089/ten.teb.2021.0045 ↗
38. Fabrication of an injectable iron (III) crosslinked alginate-hyaluronic acid hydrogel with shear-thinning and antimicrobial activities10.1016/j.carbpol.2021.117777 ↗
39. Control of the molecular degradation of hyaluronic acid hydrogels for tissue augmentation10.1002/jbm.a.31681 ↗
40. An injectable scaffold based on crosslinked hyaluronic acid gel for tissue regeneration10.1039/C5RA27870H ↗
41. Effect of hyaluronic acid initial concentration on cross-linking efficiency of hyaluronic acid—Based hydrogels used in biomedical and cosmetic applications
42. Effect of Crosslinker Topology on Enzymatic Degradation of Hydrogels10.1021/acs.biomac.0c00722 ↗
43. Effect of fibrinogen, fibrin, and fibrin degradation products on transendothelial migration of leukocytes10.1016/j.thromres.2017.11.007 ↗